机译:HSP90抑制剂NVP-Auy922,衰减Kras-突变体非小细胞肺癌中的内在PI3K抑制剂抗性
Department of Oncology Asan Medical Center University of Ulsan College of Medicine;
Department of Oncology Asan Medical Center University of Ulsan College of Medicine;
Department of Oncology Asan Medical Center University of Ulsan College of Medicine;
Department of Oncology Asan Medical Center University of Ulsan College of Medicine;
Center for Cancer Genome Discovery Asan Institute for Life Science Asan Medical Center;
Immunotherapy Convergence Research Center Korea Research Institute of Bioscience &
Biotechnology;
Department of Oncology Asan Medical Center University of Ulsan College of Medicine;
Department of Oncology Asan Medical Center University of Ulsan College of Medicine;
Department of Oncology Asan Medical Center University of Ulsan College of Medicine;
NSCLC; HSP90 inhibitor; PI3K inhibitor; KRAS mutation; Combination therapy;
机译:HSP90抑制剂NVP-Auy922,衰减Kras-突变体非小细胞肺癌中的内在PI3K抑制剂抗性
机译:HSP90抑制剂NVP-AUY922有效抑制非小细胞肺癌的生长
机译:Hsp90抑制剂NVP-AUY922通过获得对EGFR酪氨酸激酶抑制剂的抗性增强肺癌细胞的放射敏感性
机译:在非小肺癌细胞中的谱分析EGFR激酶抑制剂抵抗途径
机译:临床相关的HSP90抑制剂Auy922,A549非小细胞肺癌细胞转移和耐药性快速演变和耐药性的快速演变
机译:HSP90抑制剂NVP-Auy922有效地抑制非小细胞肺癌生长
机译:新型Hsp90抑制剂NVP-AUY922对非小细胞肺癌的强抗肿瘤作用